🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, claiming the firms hid alleged dangers that the medication created to children's neurological development.

The court filing arrives a month after Former President Trump advocated an unverified association between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism in offspring.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever recommended for women during pregnancy, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from pain and promoting medication regardless of the potential hazards."

Kenvue asserts there is insufficient reliable data tying acetaminophen to autism.

"These manufacturers misled for generations, intentionally threatening numerous people to boost earnings," the attorney general, a Republican, declared.

The company commented that it was "seriously troubled by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its official site, the company also said it had "regularly reviewed the applicable studies and there is lacking reliable evidence that demonstrates a proven link between consuming acetaminophen and autism spectrum disorder."

Organizations representing doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in acetaminophen - is among limited choices for pregnant women to address discomfort and fever, which can present significant medical dangers if ignored.

"In over twenty years of investigation on the utilization of acetaminophen in pregnancy, no reliable research has definitively established that the consumption of paracetamol in any stage of gestation causes neurodevelopmental disorders in offspring," the group stated.

This legal action cites current declarations from the previous government in claiming the medication is reportedly hazardous.

Last month, Trump generated worry from public health officials when he advised women during pregnancy to "resist strongly" not to use Tylenol when ill.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the use of Tylenol, while also stating that "a direct connection" between the medication and autism in children has remains unverified.

Health Secretary Kennedy, who oversees the FDA, had vowed in April to initiate "a massive testing and research effort" that would determine the cause of autism in a limited time.

But specialists cautioned that identifying a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of genetic and external influences - would not be simple.

Autism is a category of permanent neurological difference and disability that impacts how individuals experience and interact with the world, and is recognized using medical professional evaluations.

In his court filing, the attorney general - aligned with the former president who is campaigning for federal office - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "remove any promotional materials" that claims acetaminophen is secure for expectant mothers.

The court case mirrors the grievances of a assembly of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

A federal judge threw out the lawsuit, stating research from the plaintiffs' authorities was not conclusive.